1,017
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Lactate Dehydrogenase and Risk of Readmission with Gastric Cancer: A Propensity Score Matching Analysis

, MD, , MD, , MD, , MD, , MD, , MD, , PhD & , MD show all
Article: 2172488 | Received 23 Nov 2022, Accepted 18 Jan 2023, Published online: 12 Feb 2023

References

  • Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):1–11. doi:10.1097/CM9.0000000000001474.
  • Wu WW, Zhang WH, Zhang WY, Yang L, Deng XQ, Zhu T. Risk factors of the postoperative 30-day readmission of gastric cancer surgery after discharge: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2019;98(10):e14639. doi:10.1097/MD.0000000000014639.
  • Asaoka R, Kawamura T, Makuuchi R, et al. Risk factors for 30-day hospital readmission after radical gastrectomy: a single-center retrospective study. Gastric Cancer. 2019;22(2):413–420. doi:10.1007/s10120-018-0856-4.
  • Seidman L. The Affordable Care Act versus medicare for all. J Health Polit Policy Law. 2015;40(4):911–921. doi:10.1215/03616878-3150160.
  • Dan Z, YiNan D, ZengXi Y, XiChen W, JieBin P, LanNing Y. Thirty-day readmission after radical gastrectomy for gastric cancer: a meta-analysis. J Surg Res. 2019;243:180–188. doi:10.1016/j.jss.2019.04.076.
  • Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9(6):425–434. doi:10.1016/j.ccr.2006.04.023.
  • Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:10.1126/science.123.3191.309.
  • Smit MJ, Duursma AM, Bouma JM, Gruber M. Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. Evidence for competition by creatine kinase MM, adenylate kinase, malate, and alcohol dehydrogenase. J Biol Chem. 1987;262(27):13020–13026.
  • Ding J, Karp JE, Emadi A. Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: interplay between hematologic and solid neoplastic clones and their microenvironments. Cancer Biomark. 2017;19(4):353–363. doi:10.3233/CBM-160336.
  • Petrelli F, Cabiddu M, Coinu A, et al. Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies. Acta Oncol. 2015;54(7):961–970. doi:10.3109/0284186X.2015.1043026.
  • Jin HF, Wang JF, Shao M, Zhou K, Ma X, Lv XP. Down-regulation of miR-7 in gastric cancer is associated with elevated LDH-a expression and chemoresistance to cisplatin. Front Cell Dev Biol. 2020;8:555937. doi:10.3389/fcell.2020.555937.
  • Zhang Y, Lin S, Chen Y, Yang F, Liu S. LDH-Apromotes epithelial-mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer. Onco Targets Ther. 2018;11:2363–2373. doi:10.2147/OTT.S163570.
  • Arkenau HT, Barriuso J, Olmos D, et al. Prospective validation of a prognostic score to improve patient selection for oncology phase I trials. J Clin Oncol. 2009;27(16):2692–2696. doi:10.1200/JCO.2008.19.5081.
  • Fussenich LM, Desar IM, Peters ME, et al. A new, simple and objective prognostic score for phase I cancer patients. Eur J Cancer. 2011;47(8):1152–1160. doi:10.1016/j.ejca.2010.12.028.
  • Merchant SJ, Ituarte PH, Choi A, et al. Hospital readmission following surgery for gastric cancer: frequency, timing, etiologies, and survival. J Gastrointest Surg. 2015;19(10):1769–1781. doi:10.1007/s11605-015-2883-3.
  • Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19. doi:10.1007/s10120-016-0622-4.
  • Ajani JA, D'Amico TA, Almhanna K, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network. 2016;14(10):1286–1312. doi:10.6004/jnccn.2016.0137.
  • Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad Hoc EWG. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. Jun. 2003;22(3):321–336. doi:10.1016/S0261-5614(02)00214-5.
  • Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi:10.1097/SLA.0b013e3181b13ca2.
  • Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768. doi:10.1001/jamaoncol.2019.2996.
  • Zhuang CL, Wang SL, Huang DD, et al. Risk factors for hospital readmission after radical gastrectomy for gastric cancer: a prospective study. PLoS One. 2015;10(4):e0125572. doi:10.1371/journal.pone.0125572.
  • Ansari MZ, Collopy BT, Booth JL. Hospital characteristics associated with unplanned readmissions. Aust Health Rev. 1995;18(3):63–75.
  • Ueno T, Iida M, Yoshino S, et al. East versus west: differences in surgical management in Asia compared with Europe and North America. Surg Clin North Am. 2017;97(2):453–466. doi:10.1016/j.suc.2016.12.002.
  • Markar SR, Karthikesalingam A, Jackson D, Hanna GB. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East. Ann Surg Oncol. 2013;20(7):2328–2338. doi:10.1245/s10434-012-2862-9.
  • Lukacova S, Sorensen BS, Alsner J, Overgaard J, Horsman MR. The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models. Acta Oncol. 2008;47(5):941–947. doi:10.1080/02841860701644086.
  • Bai L, Lin ZY, Lu YX, et al. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: a two-center cohort study. Cancer Med. 2021;10(22):8005–8019. doi:10.1002/cam4.4315.
  • Kolev Y, Uetake H, Takagi Y, Sugihara K. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol. 2008;15(8):2336–2344. doi:10.1245/s10434-008-9955-5.
  • Stubbs M, McSheehy PM, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today. 2000;6(1):15–19. doi:10.1016/s1357-4310(99)01615-9.
  • Maxwell PH. The HIF pathway in cancer. Semin Cell Dev Biol. 2005;16(4–5):523–530. Aug doi:10.1016/j.semcdb.2005.03.001.
  • Li G, Gao J, Tao YL, et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Cancer. 2012;31(4):197–206. doi:10.5732/cjc.011.10283.
  • Martinez-Outschoorn UE, Prisco M, Ertel A, et al. Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via metabolo-genomics. Cell Cycle. 2011;10(8):1271–1286. doi:10.4161/cc.10.8.15330.
  • Uramoto H, Nakanishi R, Fujino Y, et al. Prediction of pulmonary complications after a lobectomy in patients with non-small cell lung cancer. Thorax. 2001;56(1):59–61. doi:10.1136/thorax.56.1.59.
  • Turna A, Solak O, Cetinkaya E, et al. Lactate dehydrodgenase levels predict pulmonary morbidity after lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;26(3):483–487. doi:10.1016/j.ejcts.2004.05.041.
  • Ball J, Venn R, Williams G, Forni L. 22nd International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 19-22 March 2002. Crit Care. 2002;6(3):264–270. doi:10.1186/cc1502.
  • Johansen MJ, Gade J, Stender S, et al. The effect of overweight and obesity on liver biochemical markers in children and adolescents. J Clin Endocrinol Metab. 2020;105(2). doi:10.1210/clinem/dgz010.
  • Sweeney JF. Postoperative complications and hospital readmissions in surgical patients: an important association. Ann Surg. 2013;258(1):19–20. Jul doi:10.1097/SLA.0b013e318297a37e.
  • Tevis SE, Kohlnhofer BM, Weber SM, Kennedy GD. Postdischarge complications are an important predictor of postoperative readmissions. Am J Surg. 2014;208(4):505–510. doi:10.1016/j.amjsurg.2014.05.013.
  • Merkow RP, Ju MH, Chung JW, et al. Underlying reasons associated with hospital readmission following surgery in the United States. JAMA. 2015;313(5):483–495. doi:10.1001/jama.2014.18614.
  • Meyer AC, Eklund H, Hedstrom M, Modig K. The ASA score predicts infections, cardiovascular complications, and hospital readmissions after hip fracture - A nationwide cohort study. Osteoporos Int. 2021;32(11):2185–2192. doi:10.1007/s00198-021-05956-w.
  • Quintana JM, Anton-Ladislao A, Lazaro S, et al. Predictors of readmission and reoperation in patients with colorectal cancer. Support Care Cancer. 2020;28(5):2339–2350. doi:10.1007/s00520-019-05050-2.